We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$1.08B
Cap. Flow
+$1.18B
Cap. Flow %
16.06%
Top 10 Hldgs %
55.65%
Holding
321
New
63
Increased
80
Reduced
61
Closed
90

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$101M
2
ICLR icon
Icon
ICLR
+$97.6M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$87.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$82.5M
5
GSK icon
GSK
GSK
+$66.7M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$40.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$36.7M
3
SHAK icon
Shake Shack
SHAK
+$32.9M
4
INCY icon
Incyte
INCY
+$30.5M
5
CYTK icon
Cytokinetics
CYTK
+$30.4M

Sector Composition

Rank Sector Weight
1 Healthcare 39.34%
2 Consumer Discretionary 6.39%
3 Consumer Staples 5.37%
4 Technology 5.27%
5 Communication Services 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVGN icon
176
Evogene
EVGN
$7.26M
$558K 0.01%
298,281
+103,589
+53% +$204K
MBRX icon
177
Moleculin Biotech
MBRX
$2.89M
$540K 0.01%
12,703
+1,103
+10% +$66.8K
COSM icon
178
Cosmos Holdings
COSM
$14.5M
$501K 0.01%
748,826
-910,024
-55% -$666K
AWH
179
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$501K 0.01%
710,000
-546,000
-43% -$444K
INSP icon
180
Inspire Medical Systems
INSP
$1.74B
$463K 0.01%
+2,500
New +$485K
NXGLW icon
181
NexGel Inc Warrant
NXGLW
$413K 0.01%
550,000
– –
WLDS icon
182
Wearable Devices
WLDS
$9.17M
$405K 0.01%
+5,167
New +$488K
QNRX
183
Quoin Pharmaceuticals
QNRX
$9.62M
$345K ﹤0.01%
+15,143
New +$348K
BEATW icon
184
Heartbeam Inc Warrant
BEATW
$41.3K
$324K ﹤0.01%
500,000
– –
EDBL
185
Edible Garden
EDBL
$1.2M
$299K ﹤0.01%
83
+50
+152% +$108K
XRTX
186
XORTX Therapeutics
XRTX
$3.69M
$299K ﹤0.01%
+53,000
New +$366K
BPTH
187
DELISTED
Bio-Path Holdings Inc
BPTH
$276K ﹤0.01%
+237,561
New +$221K
STKH
188
Steakholder Foods
STKH
$1.11M
$266K ﹤0.01%
1,295
+794
+158% +$229K
SHPH icon
189
Shuttle Pharmaceuticals
SHPH
$2.55M
$263K ﹤0.01%
+1,224
New +$319K
AYTU icon
190
AYTU BioPharma
AYTU
$25.3M
$255K ﹤0.01%
150,000
-86,000
-36% -$157K
CRIS icon
191
Curis
CRIS
$7.83M
$233K ﹤0.01%
+3,800
New +$326K
BGMS
192
Bio Green Med Solution Inc
BGMS
$5.24M
$218K ﹤0.01%
2,419
+1,815
+300% +$251K
MOBBW
193
Mobilicom Ltd Warrants
MOBBW
$2.83B
$194K ﹤0.01%
242,100
– –
KTTA icon
194
Pasithea Therapeutics
KTTA
$16.9M
$192K ﹤0.01%
+61,000
New +$216K
LCFYW icon
195
Locafy Ltd Warrant
LCFYW
$189K ﹤0.01%
12,121
– –
PALI icon
196
Palisade Bio
PALI
$367M
$174K ﹤0.01%
105,367
+53,367
+103% +$140K
VINC
197
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$149K ﹤0.01%
28,351
-106,849
-79% -$702K
SXTP icon
198
60 Degrees Pharmaceuticals
SXTP
$2.98M
$128K ﹤0.01%
+4,947
New +$109K
EVAX
199
Evaxion A/S
EVAX
$25.9M
$127K ﹤0.01%
30,092
-66,508
-69% -$654K
ONFOW icon
200
Onfolio Holdings Warrant
ONFOW
$64.5K
$120K ﹤0.01%
400,000
– –
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Armistice Capital held 321 positions worth $7.33B, up 17% from $6.25B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital deployed $1.18B of net new capital in Q4 2024, opening 63 new positions and adding to 80 existing holdings. Its largest new stake was Exact Sciences: 1,617,000 shares worth $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $36.7M trimmed.

  • Armistice Capital's largest Q4 2024 buy was Exact Sciences: 1,617,000 shares worth $90.9M.
  • Armistice Capital added most to Neurocrine Biosciences in Q4 2024, an estimated $87.9M increase.
  • Armistice Capital's biggest Q4 2024 reduction was PTC Therapeutics, cutting an estimated $36.7M.
  • Armistice Capital fully exited Alkermes in Q4 2024, selling an estimated $40.5M.
  • Armistice Capital's ten largest holdings make up 56% of its $7.33B portfolio in Q4 2024.
  • Armistice Capital opened 63 new positions and closed 90 in Q4 2024.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.